|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||0.0050 - 0.0050|
|52-week range||0.0023 - 1.4000|
|Beta (5Y monthly)||1.46|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Bloomios, Inc. (OTCQB: BLMS), a leading innovator in contract manufacturing of hemp-derived cannabinoid & mushroom edibles, cosmetic & topical sports products, nootropics and adjacent wellness supplements, has appointed Kevin Henry to the new position of national sales director.
Bloomios, Inc. (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, reported results for the first quarter ended March 31, 2023. All comparisons are to the same year-ago period unless otherwise noted.
Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, has appointed Upexi's former production division operations head, Joe Reid, as chief manufacturing officer of Bloomios' wholly owned subsidiary, Bloomios Private Label.